The RRI Group of Companies Expands Device & Pharmaceutical Capabilities
The RRI Group of Companies has added four new members to their present 18 associates who will enhance their services in device (510K and PMA) and pharmaceutical development (505(b)(2) NDA), including the development of intellectual property (IP). - April 10, 2009
Press Releases 1 - 1 of 1